Health Monitors Move to Ears; Skin Glow Screening; Imaging Isotope Shortage
Recent developments of interest in cardiovascular medicine
Mylan's valsartan was effectively banned in Europe, and 15 lots of its valsartan and valsartan-combination tablets were recalled in the U.S. after detection of the probable carcinogen N-nitrosodiethylamine. (Seeking Alpha, FDA)